This Biotech Stock 700%: Top Holding After $9.3M Sale
A biotech stock that surged 700% remains a cornerstone of many portfolios even after a sizable last-quarter sale by a...
A biotech stock that surged 700% remains a cornerstone of many portfolios even after a sizable last-quarter sale by a...
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
As macro risks rise, bitcoin pushes higher macro signals resilience in crypto. This piece breaks down what’s driving ...
A big trade in a technology-focused ETF last quarter offers more than a headline. This article digs into what investo...
When a major momentum bet is unwound, it sends signals about risk tolerance and market breadth. This article explains...
Oil has crossed the $100 mark, creating income opportunities in energy. Here are two no-brainer energy dividend stock...
The latest 2027 COLA projections show a modest uptick, but many retirees still face a gap between benefits and expens...
Monday brought a notable move for Circle Internet Group stock as rising demand for USDC underscored the crypto-stable...
AI hype meets real-world finance. This article explains why I remain cautious on CoreWeave stock, with clear risks, n...
Rivian has faced a steep stock decline since its 2021 IPO. This piece explores whether could this catalyst that sits ...
Oracle has big cloud plans, aiming for massive revenue growth by 2030. A pivotal $110 billion catalyst could make tha...